JP2004149545A5 - - Google Patents

Download PDF

Info

Publication number
JP2004149545A5
JP2004149545A5 JP2003427226A JP2003427226A JP2004149545A5 JP 2004149545 A5 JP2004149545 A5 JP 2004149545A5 JP 2003427226 A JP2003427226 A JP 2003427226A JP 2003427226 A JP2003427226 A JP 2003427226A JP 2004149545 A5 JP2004149545 A5 JP 2004149545A5
Authority
JP
Japan
Prior art keywords
thiazolylsulfonyl
yloxymethyl
indan
isobutyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003427226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004149545A (ja
JP3741120B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003427226A priority Critical patent/JP3741120B2/ja
Priority claimed from JP2003427226A external-priority patent/JP3741120B2/ja
Publication of JP2004149545A publication Critical patent/JP2004149545A/ja
Publication of JP2004149545A5 publication Critical patent/JP2004149545A5/ja
Application granted granted Critical
Publication of JP3741120B2 publication Critical patent/JP3741120B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003427226A 2001-03-12 2003-12-24 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法 Expired - Fee Related JP3741120B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003427226A JP3741120B2 (ja) 2001-03-12 2003-12-24 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001068498 2001-03-12
JP2001281569 2001-09-17
JP2002007760 2002-01-16
JP2003427226A JP3741120B2 (ja) 2001-03-12 2003-12-24 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002571480A Division JP3555620B2 (ja) 2001-03-12 2002-03-11 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005245763A Division JP4432051B2 (ja) 2001-03-12 2005-08-26 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Publications (3)

Publication Number Publication Date
JP2004149545A JP2004149545A (ja) 2004-05-27
JP2004149545A5 true JP2004149545A5 (enExample) 2005-11-17
JP3741120B2 JP3741120B2 (ja) 2006-02-01

Family

ID=27346214

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002571480A Expired - Fee Related JP3555620B2 (ja) 2001-03-12 2002-03-11 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法
JP2003427226A Expired - Fee Related JP3741120B2 (ja) 2001-03-12 2003-12-24 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法
JP2005245763A Expired - Fee Related JP4432051B2 (ja) 2001-03-12 2005-08-26 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002571480A Expired - Fee Related JP3555620B2 (ja) 2001-03-12 2002-03-11 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005245763A Expired - Fee Related JP4432051B2 (ja) 2001-03-12 2005-08-26 N−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法

Country Status (24)

Country Link
US (3) US7235667B2 (enExample)
EP (2) EP1612208B1 (enExample)
JP (3) JP3555620B2 (enExample)
KR (1) KR100886854B1 (enExample)
CN (1) CN1294126C (enExample)
AT (2) ATE522513T1 (enExample)
AU (1) AU2002238855B2 (enExample)
BR (1) BR0208027A (enExample)
CA (1) CA2439604C (enExample)
CZ (1) CZ304035B6 (enExample)
DE (1) DE60220255T2 (enExample)
DK (2) DK1369419T3 (enExample)
ES (1) ES2286230T3 (enExample)
HU (1) HU230056B1 (enExample)
IL (2) IL157701A0 (enExample)
MX (1) MXPA03008134A (enExample)
NO (1) NO329682B1 (enExample)
NZ (1) NZ528120A (enExample)
PL (1) PL218750B1 (enExample)
PT (2) PT1369419E (enExample)
RU (1) RU2299202C2 (enExample)
TW (1) TWI317359B (enExample)
WO (1) WO2002072564A1 (enExample)
ZA (1) ZA200306884B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264388A1 (en) * 2002-09-09 2004-03-29 Ono Pharmaceutical Co., Ltd. Process for producing 4-methyl-1,3-thiazol-2-ylsulfonyl halide
DK1603893T3 (da) * 2003-01-29 2008-09-08 Asterand Uk Ltd EP4 -Receptorantagonister
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
EP1642594A1 (en) * 2003-06-27 2006-04-05 Ono Pharmaceutical Co., Ltd. Remedy for urinary tract diseases
GB0401334D0 (en) * 2004-01-21 2004-02-25 Novartis Ag Organic compounds
US20080033018A1 (en) * 2004-07-05 2008-02-07 Chugai Seiyaku Kabushiki Kaisha Therapeutic Agents For Overactive Bladder
JP2008189549A (ja) * 2005-05-12 2008-08-21 Astellas Pharma Inc カルボン酸誘導体またはその塩
JP2009057282A (ja) * 2005-12-19 2009-03-19 Astellas Pharma Inc カルボン酸誘導体又はその塩
TW200817319A (en) * 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
EP2123273B1 (en) 2007-02-16 2013-10-23 ONO Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
EP2177512B1 (en) * 2007-08-01 2012-04-18 Taisho Pharmaceutical Co., Ltd. Inhibitor of binding of s1p1
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
EP2305641A4 (en) * 2008-06-23 2012-08-22 Astellas Pharma Inc SULPHONAMIDE COMPOUND OR SALT THEREOF
TW201107309A (en) * 2009-07-27 2011-03-01 Kissei Pharmaceutical Indole derivatives, or the pharmaceutically acceptable salts
JP2013532688A (ja) 2010-07-26 2013-08-19 ブリストル−マイヤーズ スクイブ カンパニー Cyp17阻害剤として有用なスルホンアミド化合物
JP5363636B2 (ja) * 2011-10-21 2013-12-11 ファイザー・リミテッド 新規な塩および医学的使用
US20140039004A1 (en) * 2012-07-31 2014-02-06 Ono Pharmaceutical Co., Ltd. Method of treating of gastroesophageal reflux disease
PT3138633T (pt) * 2014-04-30 2019-02-01 Ind Penalver Sl Cabeça concêntrica programável para aplicação de líquido em tampas de diferentes formatos
EP3375782B1 (en) * 2015-11-13 2020-07-29 Daewoong Pharmaceutical Co., Ltd. Sodium channel blocker
RU2659955C1 (ru) * 2017-10-26 2018-07-04 Галина Ильхамовна Лукина Способ диагностики высоких гастроэзофагеальных рефлюксов

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5748534B2 (enExample) * 1974-03-04 1982-10-16
DE2419923A1 (de) * 1973-04-28 1974-11-28 Fujisawa Pharmaceutical Co Sulfonsaeureester, verfahren zu deren herstellung und verwendung derselben als kondensationsmittel
DE2555048A1 (de) * 1975-12-06 1977-06-30 Pfersee Chem Fab Verfahren und vorrichtung zur herstellung bestaendiger, waessriger emulsionen wasserunloeslicher substanzen
JPS5293469A (en) * 1976-02-02 1977-08-05 Fuji Photo Film Co Ltd Method of curing gelatin
JPH05293469A (ja) 1992-04-17 1993-11-09 Toda Constr Co Ltd 滅菌精製水の製造方法およびその装置
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
WO2000069465A1 (en) * 1999-05-12 2000-11-23 Ono Pharmaceutical Co., Ltd. Anticancer agents containing ep1 antagonists as the active ingredient
KR20020012639A (ko) 1999-07-29 2002-02-19 우에노 도시오 술폰아미드 유도체 및 알로디니아 치료제
CA2440374A1 (en) 2001-03-14 2002-09-19 Takayuki Maruyama A pharmaceutical composition for the treatment of depression comprising the ep1 antagonist as active ingredient

Similar Documents

Publication Publication Date Title
JP2008506632A5 (enExample)
JP2006526031A5 (enExample)
JP2006523595A5 (enExample)
JP2007518723A5 (enExample)
JP2007510800A5 (enExample)
JP2007269812A5 (enExample)
ATE369330T1 (de) O-desmethyl-venlafaxine succinat salz
JP2007508034A5 (enExample)
NO20054957D0 (no) Subtituerte karboksylsyrer
JP2005515295A5 (enExample)
JP2009520682A5 (enExample)
TWI341200B (en) Telmisartan acid addition salt
DK1585742T3 (da) Substituerede benzoylderivater som herbicider
DE60205888D1 (de) Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
JP2008513472A5 (enExample)
JP2005529611A5 (enExample)
JP2006506499A5 (enExample)
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
JP2008510815A5 (ja) プラスミノゲン活性化因子阻害剤1型(pai−1)調節剤としてのオキサゾロ−ナフチル酸
DE602004014277D1 (de) Neue Dicarbonsäurederivate
AP2005003393A0 (en) 3-(1-Ä3-(1,3-benzothiazol-6-yl) ropylcarbamoylÜcycloalkyl) propanoic acid derivatives as NEP inhibitors.
JP2002240244A5 (enExample)
NO20053753D0 (no) Karboksylsyreforbindelser.
DE60324703D1 (de) Barbitursäure derivaten.
JP2005536763A5 (enExample)